85 related articles for article (PubMed ID: 1481168)
1. [The calcium antagonist isradipine (Lomir) in the treatment of patients with essential hypertension].
Ol'binskaia LI; Morozova TE; Vartanova OA
Ter Arkh; 1992; 64(9):98-100. PubMed ID: 1481168
[No Abstract] [Full Text] [Related]
2. [The effect of isradipine on the central and cerebral hemodynamics of patients with circulatory encephalopathy and hypertension].
Lepakhin VK; Ivleva AIa; Romashova MF; Udotova SA; Zubovskiĭ LG
Eksp Klin Farmakol; 1992; 55(6):24-6. PubMed ID: 1305868
[TBL] [Abstract][Full Text] [Related]
3. [Comparative efficacy of and tolerance to prestarium and lomir in long-term treatment of hypertensive subjects].
Nesterov IuI; Ivanova IV; Gol'dberg GA
Klin Med (Mosk); 1998; 76(3):41-3. PubMed ID: 9575747
[TBL] [Abstract][Full Text] [Related]
4. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Amir M; Cristal N; Bar-On D; Loidl A
Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
[TBL] [Abstract][Full Text] [Related]
5. [The effect of Lomir (isradipine) on the tolerance for physical loading and on the gas exchange indices of patients with primary pulmonary hypertension].
Chazova IE; Belenkov IuN; Mareev VIu; Floria VG; Sinitsyn VE; Nakonechnikov SN
Ter Arkh; 1994; 66(9):54-7. PubMed ID: 7992215
[TBL] [Abstract][Full Text] [Related]
6. [The hemodynamic effects of lomir and adalat in patients with postoperative arterial hypertension].
Eremenko AA; Ziuliaeva TP; Bozh'eva LV; Borisov RIu
Anesteziol Reanimatol; 1999; (5):63-6. PubMed ID: 10560156
[TBL] [Abstract][Full Text] [Related]
7. [Hemodynamic effects calcium channel blocker isradipine (lomir) in patients with arterial hypertension during and after aortocoronary bypass surgery. I and II].
Buniatian AA; Meshcheriakov AV; Iavorovskiĭ AG; Flerov EV; Eremenko AA; Zuliaeva TP; Bozh'eva LP; Chaus NI
Anesteziol Reanimatol; 1995; (2):4-8. PubMed ID: 7645773
[No Abstract] [Full Text] [Related]
8. [Estulic (guanfacine) in the treatment of arterial hypertension].
Erina EV; Beliakova EV; Charyev KhE
Ter Arkh; 1992; 64(8):36-9. PubMed ID: 1440392
[No Abstract] [Full Text] [Related]
9. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
Burger KJ; Dehner R
Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
[TBL] [Abstract][Full Text] [Related]
10. [The use of the preparation Lomir in patients with arterial hypertension and postinfarct cardiosclerosis].
Sledzevskaia IK; Golovkov IuZh; Kryzhanovskiĭ VA
Lik Sprava; 1995; (3-4):138-40. PubMed ID: 8819946
[TBL] [Abstract][Full Text] [Related]
11. [The prolonged-action form of Lomir (isradipine) in the treatment of mild and moderate essential hypertension].
Dmitriev VV; Arabidze GG; Epifanova ON; Rogoza AN; Metelitsa TV; Mychka VB
Ter Arkh; 1996; 68(9):35-7. PubMed ID: 9005609
[TBL] [Abstract][Full Text] [Related]
12. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
Burger KJ; Anlauf M
Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
[TBL] [Abstract][Full Text] [Related]
13. [Metabolic tolerance of isradipine. Evaluation after three months of therapy].
Panuccio D; Trabatti MR; Bernardini A; Capone A
Clin Ter; 1995 Nov; 146(11):729-36. PubMed ID: 8720349
[TBL] [Abstract][Full Text] [Related]
14. [Nifedipine (corinfar) in the treatment of arterial hypertension (AHT)].
Tămaş SI; Roman L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(2):143-7. PubMed ID: 2573128
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Yodfat Y; Bar-On D; Amir M; Cristal N
J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
[TBL] [Abstract][Full Text] [Related]
16. [Lomir for the treatment of patients with essential hypertension and for the rehabilitation of patients with a history of cerebral circulatory disorder].
Dmitriev VV; Kurkova KS; Arabidze GG; Shklovskiĭ VM; Rogova AN; Metelitsa TV; Vizel' TG
Ter Arkh; 1994; 66(4):15-8. PubMed ID: 8016719
[No Abstract] [Full Text] [Related]
17. [Pharmacokinetic and pharmacodynamic effects of isradipine in patients with arterial hypertension].
Svetyĭ LI; Alekhin SN
Eksp Klin Farmakol; 2002; 65(5):35-8. PubMed ID: 12596512
[TBL] [Abstract][Full Text] [Related]
18. First clinical experience with isradipine in the treatment of hypertension in Portugal.
Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of isradipine in uncontrolled hypertension in Ethiopian patients.
Zewdu W; Habte B
Ethiop Med J; 1995 Apr; 33(2):95-102. PubMed ID: 7601086
[TBL] [Abstract][Full Text] [Related]
20. [The effect of isradipine (Lomir, Sandoz) on coronary insufficiency during the esophageal stimulation stress test].
Vainer J; Mádle A; Cepelák V; Brunát J; Smíd J
Vnitr Lek; 1991 Mar; 37(3):242-7. PubMed ID: 1827692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
